Saturday, October 03, 2026

 

Scientists develop ‘reality check’ for lab-grown human embryo models



Can we grow accurate biological versions of human embryos? Not yet, but we’re getting closer




University of Sydney

Associate Professor Pengyi Yang at his desk

image: 

Associate Professor Pengyi Yang at his desk.

view more 

Credit: University of Sydney






University of Sydney researchers have developed a powerful new way to test how closely lab-grown biological models resemble real human embryos, finding that while some models perform well, none yet fully capture the complexity of early human development.

Research on embryo models derived from stem cells, known as blastoids, offers scientists a way to study the biological events that underpin fertility, pregnancy success and early human development without relying on donated human embryos.

Models derived from stem cells could help answer questions that have long been difficult to investigate because of technical and ethical constraints. These stem-cell-derived structures are research models, not actual human embryos. Current models cannot develop into a human embryo.

However, just because something looks like an embryo, does that mean it is behaving like one biologically?

Researchers at the University of Sydney have developed a computational framework that helps answer that question. Their study systematically evaluated four leading human blastoid-generation methods and found substantial differences in how faithfully they reproduce the cell types and developmental processes seen in natural human embryos.

Published in Cell Systems, the research creates one of the most comprehensive reference maps of early human embryo development and uses it to benchmark the biological accuracy of stem-cell-derived embryo models.

Lead author Associate Professor Pengyi Yang, ARC Future Fellow in the School of Mathematics and Statistics and Unit Head of Computational Systems Biology at the Children’s Medical Research Institute, said the work provides researchers with a more objective way to understand the strengths and limitations of embryo models.

"Human embryo models have enormous potential for studying the earliest days of an embryo’s development, but there has been no consistent way to assess how accurately these reflect real human development," said Associate Professor Yang, who also leads the Trans-Regulatory Biology group at the Charles Perkins Centre.

"Our framework allows researchers to compare these models against a detailed biological reference and determine which cell types and developmental processes are faithfully reproduced, and which are not.”

HOW THEY MADE THE MAP

The team combined and harmonised more than 14,000 single-cell transcriptomes (the set of RNA molecules in a cell) from human embryos spanning key stages of their development. This allowed them to create a reference map of how cells normally differentiate and organise themselves during the days immediately before and after implantation.

They then compared that reference against four widely used blastoid-generation protocols developed by international research groups. Rather than assessing whether the models simply resembled embryos under a microscope, the researchers examined their molecular identities, developmental timing, lineage structure and other biological characteristics.

The results showed that some blastoid models reproduced all three major cell lineages of a natural human blastocyst, or the early embryo, relatively well, while others failed to accurately represent certain cell types or contained large numbers of cells that could not be confidently matched to any known embryonic state. No single model perfectly replicated a natural human blastocyst.

Associate Professor Yang said the findings highlight both the promise and current limitations of embryo models.

“The encouraging finding is that some models capture important aspects of early embryonic development relatively well, although each model has limitations,” he said.

“But our study also shows that current models are not biologically equivalent to real human embryos, and researchers need to be careful about the conclusions they draw from them.”

By providing a standardised benchmark, the researchers hope future models can be improved more rapidly and evaluated more rigorously.

“If we're going to use these systems to answer important biological questions, we first need to know what they can reliably tell us,” Associate Professor Yang said.

“Our work provides a roadmap for improving embryo models and ensuring scientific claims remain grounded in what the models can actually support.”

The researchers have made their reference datasets and benchmarking tools publicly available, enabling scientists worldwide to test new embryo models against the same standards.

DOWNLOAD photos of the researchers and a copy of the research at this link.

INTERVIEWS

Associate Professor Pengyi Yang | pengyi.yang@sydney.edu.au | +61 452 536 773

Please contact Associate Professor Yang by email or SMS first to arrange interview time. Or contact the media adviser below.

MEDIA ENQUIRIES

Marcus Strom | marcus.strom@sydney.edu.au | +61 474 269 459

Outside of work hours: please call +61 2 8627 0246 (directs to a mobile number) or email media.office@sydney.edu.au.

RESEARCH

Long, S. et al ‘Systematic transcriptomic evaluation of blastoid models of early human development’ (Cell Systems 2026) DOI: 10.1016/j.cels.2026.101738

DECLARATION

The authors declare no competing interests.

The work was supported by a National Health and Medical Research Council Investigator Grant and a Metcalf Prize for Stem Cell Research to Pengyi Yang. Raja Jothi was supported by the Intramural Research Program of the National Institutes of Health (USA) and National Institute of Environmental Health Sciences (USA).

 

Study reveals large gaps in care for youths with opioid use disorder




Retrospective cohort study led by Mass General Brigham researchers of Medicaid-enrolled 13-to-25-year-olds with opioid use disorder shows most patients do not receive timely, evidence-based treatment



Mass General Brigham






One in 100 adolescents and young adults in the United States has an opioid use disorder (OUD) and, with the rise of fentanyl in the drug supply, overdoses in this age group have risen sharply since 2019. A new study by investigators from Mass General Brigham asked whether Medicaid-enrolled 13-to-25-year-olds with OUD receive evidence-based, reliable treatment. Using eight years of national data from 229,847 adolescents and young adults, they found only half began treatment, one-third engaged in care, one-sixth received medication, and 1 in 32 continued medication for 180 days or more. Results are published today in JAMA Network Open.

“Untreated opioid use disorder in young people has both immediate and lifelong consequences, and overdoses and poisonings have become a leading cause of death in this age group,” said lead author Scott Hadland, MD, MPH, Chief of Adolescent and Young Adult Medicine at Mass General Brigham for Children. “Our findings suggest large gaps in care that are keeping this population vulnerable to premature death and poor health outcomes.”

Using health insurance claims data, researchers found that within 14 days of diagnosis, 50.7% of adolescents and young adults with an OUD initiated treatment and 32.9% engaged in care by attending two or more additional treatment sessions in the 34 days after initiating care. Of those that engaged in treatment, 46.3% began medication. The three most prescribed medications were buprenorphine, methadone, and extended-release naltrexone. Only 3.1% of adolescents and young adults with an OUD were still on a medication after 180 days, a timeframe that has become a key quality of care measure given that longer treatment is associated with better outcomes. Additionally, younger adolescents and racially minoritized youths had consistently lower progression through the stages of care.

 

“Prior to our study, little was known about how youths progress through the stages of treatment for opioid use disorder,” said Hadland. “What we found is essential to inform Medicaid plan design, service delivery, and policies to improve quality and equity in youth opioid use disorder care.”

 

Authorship: In addition to Hadland, Mass General Brigham authors include Vicki Fung, Dandi Dong, Marie-Abèle C. Bind, Meredith Glass, Margarita Alegría and George Karandinos. Additional authors include Ijeoma Opara, Sitara Weerakoon, Jonathan Rodean, Bonnie T. Zima and Arthur Robin Williams.

Disclosures: Hadland reports grants from the National Institute on Drug Abuse during the conduct of the study; honoraria from the American Academy of Pediatrics, American Society of Addiction Medicine and American Dental Association; and fees for media appearances from TEGNA. Additional author disclosures can be found in the paper.

Funding: This study was funded by the National Institutes of Health (R01DA057566, K18DA059913, R34DA062280 and DP5OD029636).

Paper cited: Hadland SE et al. “Opioid Use Disorder and Evidence-Based Care Among Medicaid-Enrolled Youths,” JAMA Network Open DOI: 10.1001/jamanetworkopen.2026.37263

 

LSTM announces new £4.5 million partnership to tackle neglected tropical diseases



Liverpool School of Tropical Medicine
A patient with lymphatic filariasis

image: 

A patient with lymphatic filariasis

view more 

Credit: Liverpool School of Tropical Medicine



 

Liverpool School of Tropical Medicine (LSTM) has announced a new partnership to develop innovative, acceptable and feasible tools to accelerate progress towards eliminating two neglected tropical diseases (NTDs).

 

ENDPOINT (rEsearch aNd DeveloPment fOr elimInation of NTds) is a major UK aid-funded initiative coordinated by LSTM’s Centre for Drugs and Diagnostics and Centre for Neglected Tropical Diseases, working with the LSTM-led Infection Innovation Consortium (iiCON) and The Leprosy Mission in Nepal, University of Buea, Cameroon and University of Bonn in Germany.

 

The programme focuses on the filarial parasitic infections lymphatic filariasis and onchocerciasis. Together these debilitating diseases affect an estimated 78 million people, with a further one billion at risk, causing major health problems and significantly undermining economic prosperity in endemic communities.

 

As a cross-disciplinary product development partnership (PDP), ENDPOINT will advance a pipeline of innovative diagnostic and treatment tools, while generating evidence on their acceptability and feasibility within affected communities and health systems, as well as potential policy and regulatory pathways.

 

The £4.5m project is funded by UK aid through the UK Government’s Foreign, Commonwealth and Development Office (FCDO) as part of the Global Research and Technology Development fund, launched earlier this year, which supports PDPs like ENDPOINT to tackle global challenges like neglected tropical diseases.

 

Professor Joseph Turner, co-director of the Centre for Drugs and Diagnostics and research director of the PDP, said: “We are immensely grateful for this valuable FCDO investment in our CDD iiCON filarial NTDs product development portfolio.

 

“With our partners in Nepal and Cameroon, our pipeline of innovative diagnostic and therapeutic candidates have been selected to overcome specific barriers to lymphatic filariasis and onchocerciasis elimination.

 

“We will evaluate candidate product effectiveness and acceptability by affected communities in order to refine and accelerate their onward development.”

 

ENDPOINT brings together a portfolio of complementary projects:

  • a wearable microwave biosensor diagnostic to support non-invasive detection and surveillance of lymphatic filariasis in Nepal;
  • repurposing the oral antibiotic fusidic acid as a shorter-course treatment for onchocerciasis (the second leading infectious cause of blindness worldwide), complementing the LSTM-led FAME study;
  • early development of a new class of fast-acting anti-Wolbachia drug candidates in the UK, with the potential to treat or prevent onchocerciasis, lymphatic filariasis and veterinary zoonotic filariasis.

 

Dr Rachael Thomson, Endpoint CEO, said: “To receive this funding is a real achievement for ENDPOINT and LSTM. This investment strengthens the global research pipeline for NTDs and reinforces our commitment to delivering equitable, impactful solutions for affected communities.”

 

By combining cutting-edge technologies with strong in-country partnerships, ENDPOINT aims to generate high-quality evidence, support and de-risk the development of scalable solutions that are acceptable to communities and health systems, and strengthen national research and development capacity in endemic countries.

 

FAME is a complementary clinical trial funded by a £4.9 million award from the European and Developing Countries Clinical Trials Partnership (EDCTP3), with additional support from the Drugs for Neglected Diseases initiative (DNDi).

The study is generating critical evidence on the potential of repurposing the antibiotic fusidic acid to treat onchocerciasis and support the future uptake of antibiotic-based tools for filarial disease elimination.

Together, ENDPOINT and FAME represent nearly £9.4 million in new investment reaffirming LSTMs long-standing leadership in research and development to progress filarial NTD elimination.

Find out more about research and innovation at LSTM.

 

New editorial in special issue calls for stronger disaster preparedness for older adults


Authors emphasize the need for coordinated, age-inclusive disaster response strategies as climate-related and other emergencies increasingly affect older adults



SAGE






TAMPA, Fla. (Sept. 23, 2026) —

For older adults, no disaster is simple. In the opening editorial “Complex Emergencies and the Effects on Older Populations,” published in the October 2026 special issue of the Journal of Applied Gerontology, author and special issue guest editor Lindsay Peterson, PhD, explains how hurricanes, floods, wildfires, extreme heat, and other hazards can interact with chronic health conditions, reduced mobility, diminished social supports, and repeated disaster exposure to make preparation and recovery especially difficult.

Peterson introduces the special issue as an examination of the complexity of disasters and their effects on older adults in the United States, Puerto Rico, and China, across home- and community-based care, assisted living, and nursing homes. The editorial emphasizes that disaster exposure is rarely limited to one event and that outcomes often reflect risks and circumstances established long before an emergency occurs.

Across 12 studies, researchers examine how childhood adversity, extreme heat, air pollution, and multiple losses after hurricanes can shape cognitive function, mental health, and daily functioning later in life. Other studies show that disasters can cause sustained disruptions to home health and therapy services beyond the central disaster zone, while pre-existing differences in staffing, organizational structure, and resident involvement can leave assisted living communities and nursing homes unevenly prepared.

The editorial also highlights persistent gaps in individual preparedness. Even older adults with chronic illness or prior disaster experience may lack plans for continuing medical care during a power outage or emergency. At the same time, experience, resilience, hope, self-efficacy, caregiving relationships, and access to information emerge as factors that can strengthen preparedness and recovery.

“Motivation alone is not enough,” said Peterson, of the University of South Florida School of Aging Studies. “Older adults need information that is timely, relevant, and meets their needs and life circumstances. And they need better support from all the organizations with a role in disaster

planning and recovery, from emergency management and health care providers to home care, respite, and long-term care facilities.”

“Disasters do not only threaten physical health. For older adults, they can cut people off from normal routines, relationships, and the caregivers they rely on. Those losses can have lasting psychological effects,” said special issue guest editor Lisa M. Brown, PhD, ABPP, of the Department of Clinical Psychology at Palo Alto University. “When preparedness includes mental health, caregiver support, and trauma-informed care, older adults—and the staff and families who care for them—will be better able to cope during a crisis and throughout recovery.”

“Disasters are apolitical events,” said special issue guest editor David M. Dosa, MD, MPH, professor of medicine and chief of geriatrics at UMass Chan Medical School. “We must do our very best as a society to understand how best to prepare for and respond to disasters. Articles like the ones in this special issue can help us do just that and must be encouraged.”

The editorial points toward interventions that integrate disaster planning into routine clinical care, build organizational capacity in assisted living communities and nursing homes, tailor preparedness approaches to facilities’ geographic and structural differences, and create community-based programs that account for the full range of older adults’ circumstances, particularly in rural areas.

Taken together, the studies show that disaster vulnerability in later life cannot be understood by looking at a single event in isolation. Preparedness and recovery depend on the accumulation and interaction of prior experiences, health and social conditions, institutional capacity, geography, and access to trustworthy information.

By strengthening modifiable factors such as resilience, self-efficacy, caregiving relationships, and access to information—and by addressing gaps in the systems on which older adults rely—communities can improve safety and security before, during, and after disasters.


The editorial, “Complex Emergencies and the Effects on Older Populations,” by Lindsay Peterson, PhD, published in the Journal of Applied Gerontology, will be free to access in perpetuity and can be accessed here.


Journal of Applied Gerontology is the official journal of the Southern Gerontological Society. Journal of Applied Gerontology features articles that focus on research applications intended to improve the health and quality of life of older persons or to enhance our understanding of age-related issues that will eventually lead to such outcomes. We construe application to include original investigations or meta-analyses/systematic reviews that have significant clinical, policy, and/or practice implications. Rigorous studies of theoretical, conceptual, or methodological issues pertaining to research application are also welcome.

 

U.S. Employment for people with disabilities in September: Surpassing 40% for the first time


nTIDE October 2026 Jobs Report


Kessler Foundation

nTIDE Month-to-Month Comparison of Labor Market Indicators for People with and without Disabilities

image: 

Despite signs of a slowing U.S. labor market in September, employment and labor force participation increased for people with disabilities. From August 2026 to September 2026, the employment-to-population ratio rose from 39.8 to 40.3 percent for people with disabilities and from 74.6 to 75.0 percent for people without disabilities. The labor force participation rate increased from 43.4 to 43.8 percent for people with disabilities and from 77.9 to 78.1 percent for people without disabilities.

view more 

Credit: Kessler Foundation





East Hanover, NJ – October 2, 2026 – Although U.S. job growth slowed in September, employment among Americans with disabilities continued to rise, with the employment-to-population ratio reaching an all-time high of 40.3 percent. The milestone increase came during a month in which the nation added 29,000 jobs, and the official unemployment rate edged up to 4.2 percent. That’s according to today’s National Trends in Disability Employment (nTIDE) Jobs Report, issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability. nTIDE tracks employment and labor force trends for people with and without disabilities.

Based on data from today’s BLS Jobs Report and nTIDE analysis, the employment-to-population ratio for people with disabilities (ages 16-64) increased from 39.8 percent in August 2026 to 40.3 percent in September 2026 (up 1.3 percent or 0.5 percentage points). For people without disabilities (ages 16-64), the employment-to-population ratio increased from 74.6 percent in August 2026 to 75 percent in September 2026 (up 0.5 percent or 0.4 percentage points). The employment-to-population ratio, a key indicator, is the percentage of people who are working relative to the total population (the number of people working divided by the total population, then multiplied by 100).

"The employment-to-population ratio for people with disabilities was at an all-time high of 40.3 percent in September, breaking through the post-COVID employment plateau," said John O’Neill, PhD, director of the Center for Employment and Disability Research at Kessler Foundation. "Last month's numbers may have broken through the 40 percent barrier due to rising prices, necessitating people with disabilities to work to help support their families."

Month-to-Month nTIDE Numbers (comparing August 2026 to September 2026)
The labor force participation rate for people with disabilities (ages 16-64) slightly increased from 43.4 percent in August 2026 to 43.8 percent in September 2026 (up 0.9 percent or 0.4 percentage points). Similarly, for people without disabilities (ages 16-64), the labor force participation rate slightly increased from 77.9 percent in August 2026 to 78.1 percent in September 2026 (up 0.3 percent or 0.2 percentage points). The labor force participation rate reflects the percentage of people who are in the labor force (working, actively looking for work in the last four weeks, or on temporary layoff/furlough) relative to the total population (the number of people in the labor force divided by the number of people in the total population multiplied by 100).

“The labor market figures for people with disabilities over the past two months have been remarkable,” said Andrew Houtenville, PhD, professor of economics and director of the UNH-IOD. “The labor force participation of people with disabilities also reached a record level, 43.8 percent in September,” he added.

Year-to-Year nTIDE Numbers (comparing September 2025 to September 2026)
Compared with September 2025, employment and labor force participation continued to increase for people with disabilities. The employment-to-population ratio rose from 38.2 to 40.3 percent (up 2.1 percentage points), while the labor force participation rate increased from 42.1 to 43.8 percent (up 1.7 percentage points). For people without disabilities, the employment-to-population ratio increased from 74.7 to 75.0 percent (up 0.3 percentage points) and the labor force participation rate increased from 77.9 to 78.1 percent (up 0.2 percentage points).   

In September, among workers ages 16-64, the 6,918,000 workers with disabilities represented 4.6 percent of the total 151785000 workers in the U.S.
 

Ask Questions about Disability and Employment
On the same day nTIDE is issued, the team hosts an nTIDE Lunch and Learn webinar. This live Zoom broadcast gives attendees a chance to ask questions about the latest findings, hear news and updates from the field, and learn from invited panelists who discuss current disability-related research and events.

On October 2, 2026, guest presenter Charyl S. Yarbrough, PhD, of the New Jersey Department of Labor & Workforce Development, joins Drs. O’Neill and Houtenville, and Kimberly Knackstedt, executive director at the Association of University Centers on Disabilities. Visit the nTIDE archives at ResearchonDisability.org/nTIDE to see a recording of this nTIDE Lunch and Learn episode.

About National Trends in Disability Employment (nTIDE)
nTIDE is a joint effort of Kessler Foundation and the University of New Hampshire’s Institute on Disability. The nTIDE team tracks employment trends for people with and without disabilities and issues monthly reports that reflect the impact of economic changes on the workforce. These reports use data from the U.S. Bureau of Labor Statistics but are customized by UNH-IOD to focus on working-age adults (ages 16 to 64). nTIDE is funded by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR; 90RTGE0005) and Kessler Foundation.

About the Institute on Disability at the University of New Hampshire
The Institute on Disability at the University of New Hampshire, founded in 1987, seeks to expand access and opportunity for people with disabilities in ways that strengthen communities locally and nationally. As part of a Carnegie Classification R1 university, the IOD accelerates disability inclusion through research, education, and collaboration. Its Center for Research on Disability delivers trusted analysis and tools that make disability data more accessible and actionable.

About Kessler Foundation
Kessler Foundation, founded in 1985, is a New Jersey-based nonprofit and global leader in rehabilitation research committed to changing the lives of people with disabilities. By conducting groundbreaking research, Kessler Foundation advances recovery and fosters independence to build a more inclusive and accessible world.

Our team of award-winning scientists develops and tests novel interventions to transform care and optimize mobility, cognition, and quality of life for people with traumatic brain injury, spinal cord injury, stroke, multiple sclerosis, autism, and other neurological and developmental disabilities. By analyzing community and workforce participation, developing evidence-based solutions, and funding impactful community initiatives that expand employment opportunities, Kessler Foundation also addresses barriers to inclusion for people with disabilities.

Powered by a dedicated team of over 175 professionals funded by federal and state grants and private philanthropy, Kessler Foundation is redefining what is possible in rehabilitation care and recovery. For more information, visit kesslerfoundation.org.